PAR 2.17% 23.5¢ paradigm biopharmaceuticals limited..

SCN9A under Phase 2 in Australia, the Company is Olipass, does...

  1. 211 Posts.
    lightbulb Created with Sketch. 37
    SCN9A under Phase 2 in Australia, the Company is Olipass, does anyone reckon this could be competition?
    OliPass Peptide Nucleic Acid (OliPass PNA) was derived from PNA by rationally introducing cationic lipid moiety onto nucleobase. By covalently attaching such cationic lipid groups onto PNA, the cell permeability markedly improved. In addition, the affinity for RNA increased by at least a million times.
    SCN9A non-opioid painkiller
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
23.5¢
Change
0.005(2.17%)
Mkt cap ! $82.20M
Open High Low Value Volume
23.5¢ 24.0¢ 22.5¢ $186.1K 801.8K

Buyers (Bids)

No. Vol. Price($)
4 33599 23.0¢
 

Sellers (Offers)

Price($) Vol. No.
23.5¢ 65498 1
View Market Depth
Last trade - 16.10pm 23/08/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.